Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma
specificStage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ)
8
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 56.2 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 56.2 |
| 3 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 56.2 |
| 4 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 56.2 |
| 5 | Cleveland Clinic Cancer CenterCleveland, OH | 56.2 |
| 6 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 56.2 |
| 7 | University of Illinois Cancer CenterChicago, IL | 56.2 |
| 8 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →